NASDAQ:XFOR X4 Pharmaceuticals (XFOR) Earnings Date, Estimates & Call Transcripts $2.19 -0.01 (-0.45%) (As of 06/5/2023 ET) Add Compare Share Share Today's Range$2.17▼$2.3850-Day Range$0.82▼$2.2252-Week Range$0.65▼$2.41Volume2.83 million shsAverage Volume2.17 million shsMarket Capitalization$267.64 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Earnings Summary Upcoming Earnings DateAug. 3EstimatedActual EPS (Mar. 21) -$0.29 Missed By -$0.06 Consensus EPS (Mar. 21) -$0.23 Last Year's Q1 EPS (3/17/2022) -$1.24Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueXFOR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XFOR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.X4 Pharmaceuticals Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20233($0.26)($0.19)($0.22)Q2 20234($0.29)($0.17)($0.22)Q3 20234($0.23)($0.16)($0.20)Q4 20234($0.24)($0.16)($0.20)FY 202315($1.02)($0.68)($0.83) Get X4 Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for XFOR and its competitors with MarketBeat's FREE daily newsletter. XFOR Earnings Date and InformationX4 Pharmaceuticals last issued its quarterly earnings results on March 21st, 2023. The reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.06. X4 Pharmaceuticals has generated ($1.31) earnings per share over the last year (($1.31) diluted earnings per share). Earnings for X4 Pharmaceuticals are expected to grow in the coming year, from ($0.63) to ($0.47) per share. X4 Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.Read More X4 Pharmaceuticals Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/3/2023(Estimated) 3/21/2023Q4 2022($0.23)($0.29)($0.06)($0.29)11/3/2022Q3 2022($0.31)($0.26)+$0.05($0.26)8/4/2022Q2 2022($0.65)($0.60)+$0.05($0.60)5/12/2022Q1 2022($0.62)($0.72)($0.10)($0.72) 3/17/2022Q4 2021($0.68)($1.24)($0.56)($1.24) 11/4/20219/30/2021($0.72)($0.76)($0.04)($0.76) 8/3/20216/30/2021($0.73)($0.74)($0.01)($0.74) 5/6/20213/31/2021($0.84)($1.30)($0.46)($1.30) 3/4/202112/31/2020($0.87)($0.91)($0.04)($0.91) 11/5/2020Q3 2020($0.74)($0.87)($0.13)($0.87)7/30/20206/30/2020($0.70)($0.76)($0.06)($0.76) 5/7/20203/31/2020($0.83)($0.56)+$0.27($0.56)$3.00 million 3/12/202012/31/2019($0.83)($0.66)+$0.17($0.66) 11/7/2019Q3 2019($0.95)($0.95)($0.68)8/6/2019Q2 2019($0.84)($1.02)($0.18)($1.02)5/15/2019Q1 2019($6.67)($6.67)($6.67)11/9/2018Q3 2018($2.94)($4.56)($1.62)($4.56)8/13/2018Q2 2018($4.80)($5.10)($0.30)($5.10)5/10/2018Q1 2018($7.44)($4.44)+$3.00($4.44)3/9/2018Q4 2017($18.30)($10.08)+$8.22($10.08)X4 Pharmaceuticals Earnings - Frequently Asked Questions When is X4 Pharmaceuticals's earnings date? X4 Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on XFOR's earnings history. Did X4 Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, X4 Pharmaceuticals (NASDAQ:XFOR) missed the analysts' consensus estimate of ($0.23) by $0.06 with a reported earnings per share (EPS) of ($0.29). Learn more on analysts' earnings estimate vs. XFOR's actual earnings. How much revenue does X4 Pharmaceuticals generate each year? X4 Pharmaceuticals (NASDAQ:XFOR) has a recorded annual revenue of $3 million. How much profit does X4 Pharmaceuticals generate each year? X4 Pharmaceuticals (NASDAQ:XFOR) has a recorded net income of -$93.87 million. XFOR has generated -$1.31 earnings per share over the last four quarters. What is X4 Pharmaceuticals's EPS forecast for next year? X4 Pharmaceuticals's earnings are expected to grow from ($0.63) per share to ($0.47) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Molecular Partners Earnings Results Sangamo Therapeutics Earnings Results Poseida Therapeutics Earnings Results Ikena Oncology Earnings Results Caribou Biosciences Earnings Results Acumen Pharmaceuticals Earnings Results Fusion Pharmaceuticals Earnings Results Fennec Pharmaceuticals Earnings Results Sutro Biopharma Earnings Results ProKidney Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Trading Channel Breakout in Lululemon Brought by EarningsNordstrom's Earnings Beat, A Rally In The MakingMacy's Stock Earnings, A Pivotal StoryC3.AI's Lukewarm Earnings: Failing to Cash in on AI Boom?NetApp Is Gearing Up To Breakout After Earnings Top EstimatesWhat U-Haul Earnings Are Showing, Heading Up?Can Earnings Narrow The Value Gap In Hewlett Packard? This page (NASDAQ:XFOR) was last updated on 6/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.